Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
30 01 2019
30 01 2019
Historique:
received:
01
08
2018
accepted:
14
12
2018
entrez:
1
2
2019
pubmed:
1
2
2019
medline:
12
5
2020
Statut:
epublish
Résumé
Cancer is known to result from a combination of a small number of genetic defects. However, the specific combinations of mutations responsible for the vast majority of cancers have not been identified. Current computational approaches focus on identifying driver genes and mutations. Although individually these mutations can increase the risk of cancer they do not result in cancer without additional mutations. We present a fundamentally different approach for identifying the cause of individual instances of cancer: we search for combinations of genes with carcinogenic mutations (multi-hit combinations) instead of individual driver genes or mutations. We developed an algorithm that identified a set of multi-hit combinations that differentiate between tumor and normal tissue samples with 91% sensitivity (95% Confidence Interval (CI) = 89-92%) and 93% specificity (95% CI = 91-94%) on average for seventeen cancer types. We then present an approach based on mutational profile that can be used to distinguish between driver and passenger mutations within these genes. These combinations, with experimental validation, can aid in better diagnosis, provide insights into the etiology of cancer, and provide a rational basis for designing targeted combination therapies.
Identifiants
pubmed: 30700767
doi: 10.1038/s41598-018-37835-6
pii: 10.1038/s41598-018-37835-6
pmc: PMC6353925
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1005Commentaires et corrections
Type : ErratumIn
Références
Curr Opin Oncol. 2018 Jan;30(1):23-29
pubmed: 29076966
Breast Cancer Res Treat. 2005 May;91(2):121-4
pubmed: 15868439
Int J Biochem Cell Biol. 2013 Jun;45(6):1031-41
pubmed: 23474367
Br J Cancer. 1953 Mar;7(1):68-72
pubmed: 13051507
Bioinformatics. 2016 Sep 1;32(17):i736-i745
pubmed: 27587696
Nat Biotechnol. 2012 Jul 10;30(7):679-92
pubmed: 22781697
Zhonghua Bing Li Xue Za Zhi. 2007 Sep;36(9):614-8
pubmed: 18070451
BMC Cancer. 2004 Jun 17;4:25
pubmed: 15202948
Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):15095-100
pubmed: 12415112
J Mol Diagn. 2014 Jan;16(1):75-88
pubmed: 24211364
BMC Bioinformatics. 2014 Sep 19;15:308
pubmed: 25236784
Sci Rep. 2017 Feb 24;7:43169
pubmed: 28233799
Cell. 1996 Oct 18;87(2):159-70
pubmed: 8861899
Front Oncol. 2015 Dec 21;5:288
pubmed: 26732534
PLoS Genet. 2016 Oct 10;12(10):e1006193
pubmed: 27723796
BMC Bioinformatics. 2018 Jun 5;19(1):214
pubmed: 29871594
BMC Cancer. 2012 Jun 22;12:266
pubmed: 22727333
Cancer Immunol Immunother. 2009 Jun;58(6):855-65
pubmed: 18841361
Haematologica. 2009 Aug;94(8):1164-9
pubmed: 19586940
Cancer Genet. 2012 Oct;205(10):479-87
pubmed: 22939227
Am J Physiol Cell Physiol. 2006 Sep;291(3):C433-44
pubmed: 16611738
Drugs. 2018 Sep;78(14):1509-1516
pubmed: 30209701
Oncol Res. 2016;23(1-2):13-20
pubmed: 26802646
Br J Cancer. 1969 Jun;23(2):313-28
pubmed: 5788039
BMC Bioinformatics. 2013 Aug 10;14:244
pubmed: 23937229
Nature. 2010 Jan 14;463(7278):191-6
pubmed: 20016485
Tumour Biol. 2008;29(3):145-51
pubmed: 18612219
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Ecancermedicalscience. 2015 May 21;9:541
pubmed: 26082798
Clin Cancer Res. 1998 Oct;4(10):2433-7
pubmed: 9796975
Tissue Antigens. 2008 Feb;71(2):114-26
pubmed: 18069935
Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):118-23
pubmed: 25535351
Mol Biol Rep. 2013 Jan;40(1):27-33
pubmed: 23117283
Cancer Res. 2016 Oct 1;76(19):5605-5609
pubmed: 27550448
Br J Cancer. 1954 Mar;8(1):1-12
pubmed: 13172380
J Cell Biol. 2015 Sep 14;210(6):1013-31
pubmed: 26370503
Cancer Cell. 2016 Aug 8;30(2):214-228
pubmed: 27478040
Cold Spring Harb Perspect Med. 2017 Apr 3;7(4):
pubmed: 28270529
Thyroid. 2016 Jun;26(6):794-7
pubmed: 27089969
Am J Clin Pathol. 2011 Feb;135(2):245-52
pubmed: 21228365
PLoS Comput Biol. 2019 Mar 7;15(3):e1006881
pubmed: 30845172
Nat Genet. 2016 Oct;48(10):1288-94
pubmed: 27618449
Oncogene. 2007 Oct 4;26(45):6566-76
pubmed: 17471237
FEBS Lett. 2003 Feb 11;536(1-3):45-50
pubmed: 12586336
Cancer Cell. 2009 Apr 7;15(4):304-14
pubmed: 19345329
Nature. 2016 Apr 14;532(7598):162-4
pubmed: 27075078
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Eur J Obstet Gynecol Reprod Biol. 1999 Sep;86(1):69-71
pubmed: 10471145
Cancer Res. 2008 Jul 1;68(13):5104-12
pubmed: 18593909
Nat Rev Cancer. 2017 Apr;17(4):239-253
pubmed: 28256574
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
Oncogene. 2009 Jan 29;28(4):555-64
pubmed: 18978817
Int J Cancer. 2010 Nov 15;127(10):2292-9
pubmed: 20162577
Math Biosci. 2003 Jun;183(2):111-34
pubmed: 12711407
Clin Cancer Res. 2006 Dec 15;12(24):7284-93
pubmed: 17189400
Cell Mol Biol Lett. 2016 Dec 3;21:27
pubmed: 28536629
Bioinformatics. 2013 Sep 15;29(18):2238-44
pubmed: 23884480
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210
Bioinformatics. 2014 Sep 1;30(17):i572-8
pubmed: 25161249
Gastroenterology. 2015 Mar;148(3):556-64
pubmed: 25479140
Lancet Oncol. 2018 Feb;19(2):169-180
pubmed: 29337092
Genome Res. 2012 Aug;22(8):1589-98
pubmed: 22759861
Histol Histopathol. 2015 Oct;30(10):1155-60
pubmed: 26147657